A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
Clinical trial NCT05388916 · COMPLETED
Trial details
- NCT number
- NCT05388916
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-08
- Primary completion
- 2025-02-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.